logo

Aclaris Therapeutics (ACRS)



Trade ACRS now with
  Date
  Headline
6/8/2021 7:13:13 AM Aclaris Therapeutics Announces Positive Preliminary Topline Data From Phase 2a Trial Of ATI-1777 For Atopic Dermatitis
3/15/2021 7:18:16 AM Aclaris Therapeutics Completes Enrollment In Phase 2a Clinical Trial Of ATI-1777
1/19/2021 7:08:59 AM Aclaris Announces Positive Preliminary Data From 12-Week Phase 2a Trial Of Oral ATI-450 For Rheumatoid Arthritis
6/17/2020 7:09:37 AM Aclaris Therapeutics Says FDA Allows IND To Study ATI-450 In Hospitalized Patients With COVID-19
1/8/2020 8:20:23 AM Aclaris Therapeutics Names Vincent Milano To Board
9/12/2017 9:54:14 AM William Blair Reiterates Aclaris Therapeutics (ACRS) At Ourperform
3/16/2017 9:10:40 AM William Blair Is Cutting Aclaris Therapeutics (ACRS) FY18 Rev. Estimate To 30.2 M From 55.6 M
3/16/2017 9:10:16 AM William Blair Is Cutting Aclaris Therapeutics (ACRS) FY18 Estimate To -4.10 From -1.20
3/16/2017 9:10:00 AM William Blair Is Lowering Aclaris Therapeutics (ACRS) FY17 Estimate To -3.57 From -3.35